Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Jeffrey S Heier, Arshad M Khanani, Carlos Quezada-Ruiz, Karen Basu, Philip J Ferrone, Christopher J. Brittain and 24 more
- Rank
- 31 of 1,326
- Percentile
- top 2.4%
- Where
- The Lancet, 2022
- Citations
- 783
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.